[HTML][HTML] Carcinoid syndrome: preclinical models and future therapeutic strategies
Carcinoid syndrome represents a debilitating paraneoplastic disease, caused by the
secretion of several substances, occurring in about 10–40% of patients with well …
secretion of several substances, occurring in about 10–40% of patients with well …
Carcinoid Syndrome: Preclinical Models and Future Therapeutic Strategies.
G Vitale, S Carra, Y Alessi, F Campolo… - International …, 2023 - search.ebscohost.com
Carcinoid syndrome represents a debilitating paraneoplastic disease, caused by the
secretion of several substances, occurring in about 10–40% of patients with well …
secretion of several substances, occurring in about 10–40% of patients with well …
Carcinoid Syndrome: Preclinical Models and Future Therapeutic Strategies
G Vitale, S Carra, Y Alessi… - International …, 2023 - pubmed.ncbi.nlm.nih.gov
Carcinoid syndrome represents a debilitating paraneoplastic disease, caused by the
secretion of several substances, occurring in about 10-40% of patients with well …
secretion of several substances, occurring in about 10-40% of patients with well …
Carcinoid Syndrome: Preclinical Models and Future Therapeutic Strategies
G Vitale, S Carra, Y Alessi, F Campolo… - International …, 2023 - search.proquest.com
Carcinoid syndrome represents a debilitating paraneoplastic disease, caused by the
secretion of several substances, occurring in about 10–40% of patients with well …
secretion of several substances, occurring in about 10–40% of patients with well …
Carcinoid Syndrome: Preclinical Models and Future Therapeutic Strategies
G Vitale, C Silvia, A Ylenia, F Campolo… - INTERNATIONAL …, 2023 - iris.uniroma1.it
Carcinoid syndrome represents a debilitating paraneoplastic disease, caused by the se-
cretion of several substances, occurring in about 10–40% of patients with well-differentiated …
cretion of several substances, occurring in about 10–40% of patients with well-differentiated …
[PDF][PDF] Carcinoid Syndrome: Preclinical Models and Future Therapeutic Strategies
G Vitale, S Carra, Y Alessi, F Campolo, C Pandozzi… - Int. J. Mol. Sci, 2023 - core.ac.uk
Carcinoid syndrome represents a debilitating paraneoplastic disease, caused by the
secretion of several substances, occurring in about 10–40% of patients with well …
secretion of several substances, occurring in about 10–40% of patients with well …
Carcinoid Syndrome: Preclinical Models and Future Therapeutic Strategies.
G Vitale, S Carra, Y Alessi, F Campolo… - … Journal of Molecular …, 2023 - europepmc.org
Carcinoid syndrome represents a debilitating paraneoplastic disease, caused by the
secretion of several substances, occurring in about 10–40% of patients with well …
secretion of several substances, occurring in about 10–40% of patients with well …
[HTML][HTML] Carcinoid Syndrome: Preclinical Models and Future Therapeutic Strategies
G Vitale, S Carra, Y Alessi, F Campolo… - … Journal of Molecular …, 2023 - ncbi.nlm.nih.gov
Carcinoid syndrome represents a debilitating paraneoplastic disease, caused by the
secretion of several substances, occurring in about 10–40% of patients with well …
secretion of several substances, occurring in about 10–40% of patients with well …
Carcinoid Syndrome: Preclinical Models and Future Therapeutic Strategies
G Vitale, S Carra, Y Alessi, F Campolo… - INTERNATIONAL …, 2023 - air.unimi.it
Carcinoid syndrome represents a debilitating paraneoplastic disease, caused by the
secretion of several substances, occurring in about 10-40% of patients with well …
secretion of several substances, occurring in about 10-40% of patients with well …
[PDF][PDF] Carcinoid Syndrome: Preclinical Models and Future Therapeutic Strategies
G Vitale, S Carra, Y Alessi, F Campolo, C Pandozzi… - Int. J. Mol. Sci, 2023 - air.unimi.it
Carcinoid syndrome represents a debilitating paraneoplastic disease, caused by the
secretion of several substances, occurring in about 10–40% of patients with well …
secretion of several substances, occurring in about 10–40% of patients with well …